Telo Genomics Adopts Advanced Notice Provisions in By-Laws

About this update from Telo Genomics Corp.

[{"type":"text","content":"Telo Genomics Adopts Advanced Notice Provisions in By-LawsToronto, Ontario--(Newsfile Corp. - October 5, 2021) - Telo Genomics Corp. (TSXV: TELO) (the \"Company\" or \"TELO\") is pleased to announces its board of directors (the \"Board\") has adopted amendments to its By-Laws (the \"Amended By-Laws\") to include advance notice provisions (the \"Advance Notice Provisions\") which require shareholders of the Company (\"Shareholders\") to provide advance notice to the Company when nominating persons for election to the Board. The Advance Notice Provisions provide the required form and contents for a Shareholder to give notice and fixes the deadline by which Shareholders must submit director nominations to the Company prior to any annual or special meeting of Shareholders. The Advance Notice Provisions will: (i) facilitate orderly and efficient annual general or special meetings (\"AGSM\"); (ii) ensure that all Shareholders receive adequate notice of director nominations and sufficient information with respect to all nominees; and (iii) allow Shareholders to register an informed vote. A shareholder must provide notice (a \"Nominating Shareholder\") to the Company in proper written form and the notice must be made: in the case of an annual meeting of Shareholders, not less than 30 nor more than 65 days prior to the date of the annual meeting, provided that if the Company chooses to use notice and access to deliver meeting materials, the time frame will be not less than 40 and no more than 65 days, andif the annual meeting is to be held on a date that is less than 50 days after the date on which the first public announcement of the meeting was made (the \"Notice Date\"), notice by the Nominating Shareholder may be made not later than the close of business on the 10th day following the Notice Date; and in the case of a special meeting of Shareholders (which is not also an annual meeting) called for the purpose of electing directors (whether or not called for other purposes), not later than the close of business on the 15th day following the Notice Date. The Amended By-Laws have been approved by the board of directors, are currently in effect and will be placed before Shareholders for confirmation, approval and ratification at the next AGSM. The full text of the Advance Notice Provisions will be included in the meeting materials sent to...

More updates from Telo Genomics Corp.